Multiple Sclerosis News Today Forums Forums Treating MS MS Medications Complications from Gilenya Treatment Managed Successfully, Case Report Says

  • Complications from Gilenya Treatment Managed Successfully, Case Report Says

    Posted by MS News Today Moderator on May 18, 2018 at 7:32 am

    A case study reported the successful management of a multiple sclerosis (MS) patient who developed a rare condition in the brain — progressive multifocal leukoencephalopathy (PML) — due to treatment with Novartis Pharmaceutical’s Gilenya (fingolimod).

    The study, titled “Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study,” was published in the journal Neurology Neuroimmunology & Neuroinflammation, and you can read a summary of the research at MultipleSclerosisNewsToday.com: Complications from Gilenya Treatment Managed Successfully, Case Report Says

    What do you think about this news? Have you tried Gilenya?

    replied 6 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.